Literature DB >> 16179575

Blockade of gap junctions in vivo provides neuroprotection after perinatal global ischemia.

Mara H de Pina-Benabou1, Vanessa Szostak, Andreas Kyrozis, David Rempe, Daniela Uziel, Marcia Urban-Maldonado, Salomon Benabou, David C Spray, Howard J Federoff, Patric K Stanton, Renato Rozental.   

Abstract

BACKGROUND AND
PURPOSE: We investigated the contribution of gap junctions to brain damage and delayed neuronal death produced by oxygen-glucose deprivation (OGD).
METHODS: Histopathology, molecular biology, and electrophysiological and fluorescence cell death assays in slice cultures after OGD and in developing rats after intrauterine hypoxia-ischemia (HI).
RESULTS: OGD persistently increased gap junction coupling and strongly activated the apoptosis marker caspase-3 in slice cultures. The gap junction blocker carbenoxolone applied to hippocampal slice cultures before, during, or 60 minutes after OGD markedly reduced delayed neuronal death. Administration of carbenoxolone to ischemic pups immediately after intrauterine HI prevented caspase-3 activation and dramatically reduced long-term neuronal damage.
CONCLUSIONS: Gap junction blockade may be a useful therapeutic tool to minimize brain damage produced by perinatal and early postnatal HI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179575     DOI: 10.1161/01.STR.0000182239.75969.d8

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  62 in total

1.  Pannexins in ischemia-induced neurodegeneration.

Authors:  Panagiotis Bargiotas; Antje Krenz; Sheriar G Hormuzdi; Dirk A Ridder; Anne Herb; Waleed Barakat; Silvia Penuela; Jakob von Engelhardt; Hannah Monyer; Markus Schwaninger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-06       Impact factor: 11.205

2.  Increased p38 mitogen-activated protein kinase signaling is involved in the oxidative stress associated with oxygen and glucose deprivation in neonatal hippocampal slice cultures.

Authors:  Qing Lu; Thomas F Rau; Valerie Harris; Maribeth Johnson; David J Poulsen; Stephen M Black
Journal:  Eur J Neurosci       Date:  2011-09-21       Impact factor: 3.386

Review 3.  Novel model for the mechanisms of glutamate-dependent excitotoxicity: role of neuronal gap junctions.

Authors:  Andrei B Belousov
Journal:  Brain Res       Date:  2012-07-05       Impact factor: 3.252

4.  Gap junctional intercellular communication dysfunction mediates the cognitive impairment induced by cerebral ischemia-reperfusion injury: PI3K/Akt pathway involved.

Authors:  Shujun Zhou; Zheng Fang; Gui Wang; Song Wu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 5.  The gap junction cellular internet: connexin hemichannels enter the signalling limelight.

Authors:  W Howard Evans; Elke De Vuyst; Luc Leybaert
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

Review 6.  Disruption of ion homeostasis in the neurogliovascular unit underlies the pathogenesis of ischemic cerebral edema.

Authors:  Arjun Khanna; Kristopher T Kahle; Brian P Walcott; Volodymyr Gerzanich; J Marc Simard
Journal:  Transl Stroke Res       Date:  2013-11-22       Impact factor: 6.829

Review 7.  Ionic regulation of cell volume changes and cell death after ischemic stroke.

Authors:  Mingke Song; Shan Ping Yu
Journal:  Transl Stroke Res       Date:  2013-12-07       Impact factor: 6.829

8.  Effect of gap junction inhibition on intracerebral hemorrhage-induced brain injury in mice.

Authors:  Anatol Manaenko; Tim Lekic; Takumi Sozen; Reiko Tsuchiyama; John H Zhang; Jiping Tang
Journal:  Neurol Res       Date:  2009-03       Impact factor: 2.448

9.  Role of gap junctions in early brain injury following subarachnoid hemorrhage.

Authors:  Robert Ayer; Wanqiu Chen; Takashi Sugawara; Hidenori Suzuki; John H Zhang
Journal:  Brain Res       Date:  2009-12-16       Impact factor: 3.252

10.  Protection from ataxia-linked apoptosis by gap junction inhibitors.

Authors:  Dingbo Lin; Dolores J Takemoto
Journal:  Biochem Biophys Res Commun       Date:  2007-08-27       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.